Protein Phosphatase 1 Regulatory Subunit 3C integrates cholesterol metabolism and isocitrate dehydrogenase in chondrocytes and neoplasia

M Makoto Nakagawa (Department of Orthopaedic Surgery, Duke University) E Eijiro Shimada (Department of Orthopaedic Surgery, Duke University) N Nicholas Guardino (Department of Orthopaedic Surgery, Duke University) R Ryo Miyamoto (Department of Radiation Oncology, Duke University) V Vijitha Puviindran (Department of Orthopaedic Surgery, Duke University) E Emily Peairs (Department of Orthopaedic Surgery, Duke University) A Ariana Matarangas (Department of Orthopaedic Surgery, Duke University) K Koji Ishikawa (Department of Orthopaedic Surgery, Duke University) T Tuyet Nguyen (Department of Orthopaedic Surgery, Duke University) M Makenna Browne (Department of Orthopaedic Surgery, Duke University) C Choiselle Marius (Department of Orthopaedic Surgery, Duke University) A Asjah Wallace (Department of Orthopaedic Surgery, Duke University) M Makoto Hirata (Department of Genetic Medicine and Services, National Cancer Center Hospital) P Puviindran Nadesan (Department of Orthopaedic Surgery, Duke University) B Benjamin A. Alman (Department of Orthopaedic Surgery, Duke University)

Abstract

Enchondromas are common bone tumors composed of chondrocytes originating from growth plate cells which can progress to malignant chondrosarcoma. Mutations in the genes encoding isocitrate dehydrogenase (IDH1 and IDH2) are identified in a large proportion of these tumors. IDH enzymes convert isocitrate to alpha-ketoglutarate (α-KG), an essential component of the citric acid cycle. While mutant IDH enzymes produce 2-hydroxyglutarate, which has epigenetic effects important in tumor initiation, cell maintenance and growth rely on additional factors. Prior work shows that intracellular cholesterol and glycogen are upregulated in mutant IDH chondrocytes. Here, we show that Protein Phosphatase 1 Regulatory Subunit 3C (PPP1R3C, previously termed Protein Targeting to Glycogen or PTG) is highly expressed in chondrocytes harboring a mutant IDH. Furthermore, Sterol Regulatory Element-Binding Proteins (SREBPs), transcriptional regulators of sterol biosynthesis, regulate PPP1R3C expression. We found that PPP1R3C regulates glycolysis and glycolytic capacity in chondrocytes. Depletion of PPP1R3C in mouse chondrocytes in vivo suppresses the neoplastic phenotype. The growth plate phenotype associated with the genetic inhibition of cholesterol biosynthesis is partially rescued by PPP1R3C overexpression. Taken together, our data show that PPP1R3C integrates cholesterol metabolism and isocitrate dehydrogenase in growth plate and neoplastic chondrocyte metabolism by regulating intracellular glycogen levels.

Article Details

Volume / Issue Vol. 122, Issue 16
Published April 22, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (15)

M

Makoto Nakagawa

Department of Orthopaedic Surgery, Duke University

E

Eijiro Shimada

Department of Orthopaedic Surgery, Duke University

N

Nicholas Guardino

Department of Orthopaedic Surgery, Duke University

R

Ryo Miyamoto

Department of Radiation Oncology, Duke University

V

Vijitha Puviindran

Department of Orthopaedic Surgery, Duke University

E

Emily Peairs

Department of Orthopaedic Surgery, Duke University

A

Ariana Matarangas

Department of Orthopaedic Surgery, Duke University

K

Koji Ishikawa

Department of Orthopaedic Surgery, Duke University

T

Tuyet Nguyen

Department of Orthopaedic Surgery, Duke University

M

Makenna Browne

Department of Orthopaedic Surgery, Duke University

C

Choiselle Marius

Department of Orthopaedic Surgery, Duke University

A

Asjah Wallace

Department of Orthopaedic Surgery, Duke University

M

Makoto Hirata

Department of Genetic Medicine and Services, National Cancer Center Hospital

P

Puviindran Nadesan

Department of Orthopaedic Surgery, Duke University

B

Benjamin A. Alman

Department of Orthopaedic Surgery, Duke University